:

Yoko Yamamoto1,2,3, Kota Iwahori3,4, Yasushi Shintani2

  • 1Department of General Thoracic Surgery, Sakai City Medical Center, Osaka, Japan.

PubMed
概括

免疫疗法,包括抗编程细胞死亡-1 (抗PD-1) 抗体,显示出晚期胸膜上皮瘤 (TETs) 的潜力. 对这些治疗方法来说,对益处毒性比的仔细评估至关重要.